nach oben

Reactions Weekly

Erschienen in:

01.06.2019 | Case report

Anti-neoplastic

Various toxicities: 11 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Roberts J, et al. Hydroxychloroquine is a safe and effective steroid-sparing agent for immune checkpoint inhibitor-induced inflammatory arthritis. Clinical Rheumatology 38: 1513-1519, No. 5, May 2019. Available from: URL: http://doi.org/10.1007/s10067-019-04451-2 - Canada

Titel: Anti-neoplastic
Various toxicities: 11 case reports
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63579-3

Dimethyl-fumarate/interferon-β-1b

Case report

Antineoplastics

Case report

Hydroxychloroquine

Case report

Secukinumab

Case report

Atezolizumab/cetuximab

Case report

Multiple drugs

Case report

Springer Medizin

Anti-neoplastic

Various toxicities: 11 case reports

Excerpt

Weitere Artikel der Ausgabe 1/2019

Dimethyl-fumarate/interferon-β-1b

Antineoplastics

Hydroxychloroquine

Secukinumab

Atezolizumab/cetuximab

Multiple drugs

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Dimethyl-fumarate/interferon-β-1b

Antineoplastics

Hydroxychloroquine

Secukinumab

Atezolizumab/cetuximab

Multiple drugs